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Abstract. Misfolded membrane proteins are rapidly 
degraded, often shortly after their synthesis and inser- 
tion in the endoplasmic reticulum (ER), but the exact 
location and mechanisms of breakdown remain un- 
clear. We have exploited the requirement of MHC class 
I molecules for peptide to achieve their correct confor- 
mation: peptide can be withheld by introducing a null 
mutation for the MHC-encoded peptide transporter, 
TAP. By withholding TAP-dependent peptides, the 
vast majority of newly synthesized class I molecules 
fails to leave the endoplasmic reticulum and is de- 
graded. We used mice transgenic for HLA-B27 on a 
TAPl-deficient background to allow visualization by 
immunoelectron microscopy of misfolded HLA-B27 
molecules in thymic epithelial cells. In such HLA trans- 
genic animals, the TAP mutation can be considered a 
genetic switch that allows control over the extent of 
folding of the protein of interest, HLA-B27, while the 
rate of synthesis of the constituent subunits remains un- 
altered.,In TAPl-deficient, HLA-B27 transgenic ani- 
mals, HLA-B27 molecules fail to assemble correctly, 
and do not undergo carbohydrate modifications associ- 
ated with the Golgi apparatus, such as conversion to 
Endoglycosidase H resistance, and acquisition of sialic 
acids. We show that such molecules accumulate in an 
expanded network of tubular and fenestrated mem- 
branes. This compartment has its counterpart in normal 
thymic epithelial cells, and is identified as an ER-Golgi 
intermediate. We detect the presence of ubiquitin and 
ubiquitin-conjugating enzymes in association with this 
compartment, suggesting a nonlysosomal mode of deg- 
radation of its contents. 
I 
NDIVIDUAL subunits of glycoproteins are synthesized 
in the rough endoplasmic reticulum (RER)  1  where they 
fold and may undergo modifications such as disulfide 
bond formation and glycosylation (Hurtley and Helenius, 
1989). Because the subunits may be synthesized at differ- 
ent  rates  and not necessarily  in stoichiometric amount, 
there must be mechanisms to ensure that only properly as- 
sembled and stable complexes reach the cell surface (Rose 
and  Doms,  1988; Hurtley and  Helenius,  1989; Pelham, 
1989). Studies on the assembly of multimeric proteins such 
as the T  cell  receptor (Lippincott-Schwartz  et al.,  1988; 
Chen et al., 1988), asialoglycoprotein  receptor (Amara et 
al., 1989; Wikstrom and Lodish, 1993), acetylcholine re- 
ceptors  (Blount and Merlie,  1990), or  immunoglobulins 
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tric focussing gel; 1~2m, 132-microglobulin;  BFA, Brefeldin A; endo H, En- 
doglycosidase H; HC, class I heavy chain; h132m, human 132-microglobulin; 
MHC, major histocompatibility complex; PAG, protein A-gold; PDI, pro- 
tein disulfide isomerase; RER, rough endoplasmic reticulum; TAP, trans- 
porter associated with antigen presentation. 
(Sitia et al., 1987) show that degradation of subunits that 
have failed to assemble into the appropriate oligomers oc- 
curs at distinct rates and takes place in the ER or in a re- 
lated compartment, possibly  the ER-Golgi intermediate 
compartment (Klausner and Sitia,  1990; Bonifacino and 
Lippincott-Schwartz,  1991; Hauri  and  Schweizer,  1992). 
Misfolded proteins are not completely retained in the ER 
and can cycle between the cis-Golgi, the intermediate com- 
partment, and the ER  (Hammond and Helenius, 1994). 
Nevertheless,  the exact location of the degradative system 
and  the  mechanisms  involved  are  only poorly defined. 
Here we have taken advantage of the peculiarities  of bio- 
synthesis  and assembly  of major histocompatibility com- 
plex (MHC) class I molecules to address some of these is- 
sues in thymic epithelial cells. The question of where quality 
control of misfolded proteins occurs  has,  to our knowl- 
edge, not been addressed previously in situ. 
MHC class I molecules bind peptides derived from de- 
graded self and foreign antigens and display them on the 
surface  of cells for recognition by CD8 ÷ T lymphocytes. 
Class I molecules should be considered trimeric structures: 
they consist of a heavy chain (HC), the light chain, 132-micro- 
globulin (132m), and an ~9-amino acid long peptide (Yew- 
dell and Bennink, 1992). Peptide binding is essential  for 
the stable expression  of the complex at the plasma mem- 
brane (Elliott, 1991; Bijlmakers and Ploegh,  1993). These 
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pletely defined mechanism (Arnold et al., 1992; Momburg 
et al.,  1992;  Howard and  Seelig, 1993).  Ubiquitinylation 
and  proteolysis by proteasomes  have  been proposed  as 
major candidates (Michalek et al., 1993; Dick et al.,  1994; 
Rock et al., 1994). The resultant peptides are then translo- 
cated into the lumen of the RER by the transporter associ- 
ated with antigen presentation (TAP) (Powis et al.,  1991; 
Spies and DeMurs, 1991; Attaya et al., 1992). TAP is a het- 
erodimer composed of two subunits (TAP1 and TAP2) lo- 
cated in the ER and cis-Golgi (Kleijmeer et al., 1992), and 
is responsible for the translocation of peptides of particu- 
lar size and sequence (Androlewicz et al., 1993; Neefjes et 
al.,  1993;  Shepherd  et  al.,  1993;  Heemels  and  Ploegh, 
1995). 
TAP-deficient cell lines  such  as  the  T  lymphoma cell 
line  RMA-S  (Ljunggren  and  K/arre,  1985;  Karre  et  al., 
1986) and the B  lymphoblastoid cell lines 721.174 and its 
derivative T2 (Kavathas et al., 1980; DeMurs et al.,  1984) 
are  defective in  class  I  surface expression, although  the 
HC and [32m are synthesized normally and are clearly ca- 
pable of assembly in the absence of TAP-dependent pep- 
tides (Alexander et al.,  1989; Ljunggren et al.,  1990; Baas 
et al., 1992). In the T2 cell line these class I molecules ap- 
pear to be  retained in  the  ER  and in  the  Golgi region 
(Baas et al., 1992). In another mutant cell line, likely to be 
(perhaps not completely) TAP-deficient, unassembled class 
I molecules were shown to recycle from the Golgi to the 
ER through an intermediate compartment, underscoring 
the role of the cis-Golgi region in the quality control of un- 
assembled or misfolded molecules (Hsu et al., 1991; Boni- 
facino and Lippincott-Schwartz, 1991). 
With respect to class I  biosynthesis, cells from TAP1- 
deficient mice were shown to have characteristics similar 
to  those  of TAP-deficient  cells  already  analyzed  (Van 
Kaer et al.,  1992).  TAPl-deficient mice are  impaired in 
positive selection of CD8 ÷ cells, as a consequence of re- 
duced class I expression in thymic epithelial cells. Assem- 
bly of HLA-B27 in murine cells is critically dependent on 
peptides delivered by the TAP-dependent pathway (Ander- 
son et al., 1993; van Santen et al., 1995). 
The availability of HLA-B27 transgenic mice, together 
with the TAPl-deficient animals, therefore allows the gen- 
eration of a model in which either properly assembled, or 
unassembled class I molecules may be tracked inside the 
cell. To obtain efficient expression at the cell surface of 
human class I  molecules in transgenic mice, the simulta- 
neous  presence  of the  class  I  transgene  and  a  human 
132-microglobulin  (h132m) transgene is required (Krimpen- 
fort et al.,  1987). We have described animals in which the 
HLA-B27  and  h[32m gene  were  introduced on  a  single 
DNA fragment and where, consequently, these transgenes 
cosegregate (Baas, 1993).  These transgenic animals were 
then used to generate HLA-B27 animals lacking a func- 
tional TAP1 gene (van Santen et al.,  1995).  They may be 
used to study the behavior of class I molecules in relation 
to TAP in different tissues and in particular cell types, es- 
pecially because several monoclonal and polyclonal anti- 
bodies reactive with human class I molecules in ultrathin 
cryo-sections have been described (Stam et al.,  1990; Pe- 
ters et al., 1991; Baas et al., 1992). 
We analyzed the influence of a properly folded state, as 
determined by the presence or absence of TAP-dependent 
peptides, on the distribution of HLA-B27 HCs and human 
132m in  thymic epithelial  cells  in  situ.  Thymic epithelial 
cells are known to express high levels of class I molecules 
and play a fundamental role in thymic selection. HLA-B27 
is expressed in thymic epithelial cells of normal transgenic 
animals. In the absence of expression of TAP1, HLA-B27 
HCs are largely absent from the plasma membrane, exist 
predominantly as free HCs as assessed biochemically, and 
are degraded most likely by an ER-dependent mechanism. 
In the TAPl-deficient cells, HLA-B27 HCs and h132m are lo- 
calized in an extended post-ER/pre-Golgi network or ER- 
Golgi intermediate compartment, consisting of tubulated 
and fenestrated membranes. Compartments derived from 
the extended network and superficially similar to lysosomes 
are likely involved in a nonlysosomal pathway of degrada- 
tion of class I molecules, involving the ubiquitin pathway. 
Materials and Methods 
Mice 
TAPl-deficient mice (Van Kaer et al., 1992),  mice double-transgenic for 
HLA-B27 and human ~2  m (Baas, 1993), and the cross between these two 
strains (van Santen et al., 1995)  have been described. The mice resulting 
from this cross are referrred  to as TAP1-I3B27 mice. Their TAP-wild- 
type  counterparts are  referred  to  as  TAP1+I3B27  mice. Nontransgenic 
mice obtained during the breeding of the parental strains were used as 
controls. 
Antibodies 
The following antibodies were used: mAb W6/32 (Barnstable et al., 1978), 
recognizing properly folded human class I complexes; mAb HC10 (Stam 
et  al.,  1990),  specific for human class I  free  heavy chains (HCs);  anti- 
human HC serum (Stam et al., 1986),  specific for free human HCs; anti- 
mouse HC serum (Machold et al., 1995), recognizing free HCs only; anti-p8 
serum (raised in our laboratory, according to Smith et al. [1986], against a 
synthetic peptide representing the most COOH-terminal exon of the H-2K  b 
molecule); anti-human 132m serum (raised  against highly purified  [~2  m, 
separated from HLA-A2 and HLA-A28 by gel filtration in acetic acid); 
rabbit anti-ER serum provided by Dr. D. Louvard (Institut Pasteur, Paris, 
France)  (Louvard et al., 1982);  mouse monoclonal anti-PDI  (ID3)  pro- 
vided by Dr. S. Fuller (EMBL, Heidelberg, Germany) (Vaux et al., 1990); 
rabbit  anti-bovine cathepsin D  provided  by Dr.  G.  Jaureguiberry  (IN- 
SERM U.13, Hopital Claude Bernard, Paris, France) (Bailly et al., 1991); 
mouse monoclonal anti-ERGIC 53 provided by Dr. H. P. Hauri (Univer- 
sity of Basel, Basel, Switzerland)  (Schweizer  et  al.,  1988);  rabbit  poly- 
clonal affinity purified anti-human ubiquitin and mouse monoclonal anti- 
E1 provided by Dr. A. Schwartz (Washington University, St. Louis, MO) 
(Schwartz et al., 1988,  1992).  To visualize the primary antibodies nondi- 
rectly reactive with protein  A, rabbit  anti-mouse IgG  and rabbit  anti- 
mouse IgM (Nordic Immunochemicals, Tilburg, The Netherlands) were 
used. 
Metabolic Labeling and Immunoprecipitations 
Spleen cells were cultured for 24 h in DME medium, containing 10% FCS 
and 2.5 ixg/ml ConA. Cells were incubated for 45 min in methionine-free 
RPMI medium, labeled with 1 mCi [35S]methionine/cysteine (protein la- 
beling mix, New England Nuclear DuPont, Boston, MA) for 20 min and 
chased in DME medium, containing 10% FCS and 1 mM cold L-methio- 
nine and L-cysteine. Cells were lysed in NP-40 lysismix (0.5%  NP-40; 50 
mM Tris, pH 7.4; 5 mM MgC12; 0.1 mM PMSF) and supplemented with 10 
mg/ml BSA. 
Thymuses were cut in four segments of approximately equal size and 
incubated for 45 min in methionine-free medium, labeled for 45 min with 
800 txCi  [35S]methionine/cysteine, and chased for the indicated times in 
DME medium in presence of 1 mM cold L-methionine and L-cysteine. 
Thymocytes were removed by gently squeezing the thymic lobes with for- 
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40 lysismix, containing 10 mg/ml BSA, and homogenized in a dounce ho- 
mogenizer. 
Lysates were precleared twice with normal rabbit serum and formalin 
fixed Staphylococcus aureus, followed by the indicated MHC class I spe- 
cific antibodies and antisera. Precipitates, adjusted for total amount of in- 
corporation, were  run on one-dimensional isoelectric focusing gels (1D- 
IEF) (Neefjes and Ploegh, 1988).  Gels were fluorographed using DMSO/ 
PPO  and  exposed  to  KODAK  X-OMAT  AR  film  (Eastman-Kodak, 
Rochester, NY). 
Endo H Treatment and Immunoblotting 
Whole thymus was depleted of thymocytes as described above. The re- 
maining capsule was macerated with a razor blade and resuspended in 1% 
SDS/0.5% p-mercaptoethanol. This suspension was briefly heated to 95°C 
and vortexed twice, and sheared through a 30-G1/2 needle. The suspen- 
sion was adjusted to 50 mM NaCitrate (pH 5.5), divided into two parts and 
treated  or mock treated  with 2,000 units Endoglycosidase H  (endoHf) 
(New England Biolabs, Beverly, MA) for 2 h at 37°C. Aliquots were sepa- 
rated by SDS-PAGE and blotted to nitrocellulose. The blots were incubated 
with the indicated  first  antibodies,  followed by horseradish peroxidase 
(PO)-coupled goat anti-mouse IgG (Southern Biotechnology Associates, 
Birmingham, AL) or PO-coupled goat anti-rabbit Ig (Promega, Madison, 
WI)  antiserum. Bound antibody was detected  by a  chemoluminescence 
detection  kit  (Kirkegaard  and Perry  Laboratories,  Gaithersburg,  MD) 
and exposure to X-ray films. 
Tissue Fixation,  Processing, and Cryosectioning 
Mice were  anesthetized intraperitoneaUy with pentobarbital  (90 mg/Kg 
body weight) and the thymuses were rapidly removed, immersed in fixa- 
tive and immediately cut in small cubes (1 mm3). As fixatives, we used 4% 
paraformaldehyde (wt/vol) in 0.1 M sodium phosphate buffer pH 7.4 (PB) 
or a mixture of 2% paraformaldehyde (wt/vol), 1% (vol/vol) acroleine in 
PB. Fixation proceeded overnight and the tissue was stored in paraformal- 
dehyde 2%  (wt/vol) in PB. Processing for ultracryomicrotomy was per- 
formed as described (Raposo et al., 1995).  The small fragments were em- 
bedded in gelatin (10%; wt/vol) for 30 rain at 37°C, and then solidified on 
ice. Blocks were then immersed in 2.3 M sucrose in PB for 2 h at 4°C. Tis- 
sue blocks were mounted on specimen holders and frozen in liquid nitro- 
gen. Semithin (300-500 nm) or ultrathin sections (60-80 nm) were cut at 
-80°C  and  120°C,  respectively,  using an  Ultra-CutS  cryomicrotome 
(Leica, Biel, Switzerland) and a diamond knife (Diatome, Biel, Switzer- 
land). Semithin sections were collected with 2.3 M  sucrose and ultrathin 
sections with a mixture of methyl cellulose and 2.3 M  sucrose (Liou and 
Slot, 1994). 
Electron Microscopy 
Ultrathin  cryo-sections were  collected  on  formvar-  and  carbon-coated 
copper grids and single or double immunogold-labeled as described (Slot 
et al., 1991; Raposo et al., 1995).  Semiquantitative evaluation of the areas 
of the class I-enriched structures and determination of the density of gold 
labeling were performed as follows: class I-positive thymic epithelial cells 
were randomly selected by screening ultrathin cryo-sections immunolabeled 
with the antibodies directed against the human or the mouse HCs at low 
magnification (x2,000). For each thymus (TAPl+I3B27 and TAPl-I~B27), 
30 thymic epithelial cells were photographed at x4,000 in order to deter- 
mine the area of the cell occupied by the class I-enriched compartments 
and the same cells were photographed at x 12,000 for subsequent counting 
of gold particles representing class I HCs. The areas of the class I-enriched 
structures were determined by superimposing an appropriate lattice grid 
over  the  electron  micrographs and  by  counting the  number of points 
within each cell and within each compartment. The density of gold label- 
ing was evaluated by counting the number of gold particles labeling a par- 
ticular antigen and by relating this number to the area in p.m  2 determined 
as described above. To evaluate the labeling for HLA-B27 HCs over the 
plasma membrane of thymic epithelial cells, a  lattice grid was superim- 
posed over 30 micrographs or directly on a video screen. The number of 
gold particles counted over the plasma membrane is related to the number 
of intersections with  the membrane and  expressed as goldhxm plasma 
membrane length. 
Immunofluorescence 
Semithin cryosections were  placed  on poly-L-lysine-coated glass slides, 
quenched with 0.1  M  glycine in PBS for 10 min, incubated with the pri- 
mary antibody in 1% (wt/vol) BSA in PBS for 45 rain. After several wash- 
ings in 0.1%  BSA, the sections were incubated with TRITC-conjugated 
rabbit  anti-mouse IgG or goat anti-rabbit  IgG  (Nordic  Immunochemi- 
cals) for 30 min. All incubations proceeded at room temperature. After 
rinsing with water, sections were  mounted in Mowiol and examined by 
epifluorescence with a Reichert-Polyvar photomicroscope. 
Results 
Assembly and Intracellular  Transport of HLA-B27 Is 
Dependent on Proper TAP Function 
We  analyzed  the  assembly,  intracellular  transport,  and 
steady-state distribution of HLA-B27 in spleen cells and 
the  thymus  from  TAPl-wild-type  mice  transgenic  for 
HLA-B27 and hp2m (TAPl+pB27), and their TAPl-defi- 
cient  counterparts  (TAPl-pB27).  Initially,  splenocytes 
were chosen for biochemical analysis as they can be ob- 
tained as single cell suspensions of high viability that show 
excellent incorporation of label. Biosynthetic labeling of 
thymus fragments was performed to allow a  more direct 
comparison with the immunocytochemistry to be described 
below.  Con  A-stimulated  spleen cells  and  thymic lobes 
were labeled for 20 min and 45 rain, respectively, and chased 
for up to 4 h. Two monoclonal antibodies were used to im- 
munoprecipitate the HLA-B27 molecules: W6/32, specific 
for properly assembled human class I complexes (Barnsta- 
ble et al., 1978), and HC10, recognizing only free human 
class I heavy chains (Stare et al., 1986).  The immunopre- 
cipitates were analyzed on 1D-IEF gels to monitor addi- 
tion of sialic acids upon arrival of class I molecules in the 
TGN,  causing  a  shift  towards  a  more  acidic  iso-electric 
point. 
Most of the HLA-B27 heavy chains in the TAPl+pB27 
splenic blasts have formed a complex with hp2m at the on- 
set of the chase, and can be immunoprecipitated with the 
W6/32 antibody (Fig.  1 A, first panel). During the chase 
these complexes acquire sialic acids,  indicating that they 
have moved through the Golgi and have reached the TGN. 
Only a few of the HLA-B27 molecules in TAP1 ÷ cells are 
present as free heavy chains (Fig. 1 A, third panel). In sple- 
nocytes, some of the free heavy chains acquire sialic acid 
and then decrease over the chase period, showing that break- 
down occurs. The observation that in TAP1 ÷ cells some 
HLA-B27 free heavy chains occur in a sialylated form, is 
most likely caused by dissociation  of complexes formed 
early on due to a reduced affinity of HLA-B27 for murine 
self peptides,  likely to  be  of different composition than 
their human counterparts. Sialylated free HCs are not ob- 
served in human cells (Neefjes and Ploegh, 1988; Baas et 
al.,  1992). The murine TAP complex is unable to translo- 
cute peptides that terminate in  a positively charged resi- 
due,  yet  such  residues  are  abundant  among  HLA-B27 
ligands in human cells ( Heemels and Ploegh, 1995). 
In the TAPl-pB27 spleen cells, the ratio of assembled 
complexes vs free heavy chains is reversed: trace amounts 
of HLA-B27 heavy chains are present as a complex that 
can be recognized by W6/32, and these complexes remain 
unsialylated (Fig. 1 A, second panel). The majority of the 
HLA-B27  molecules,  however, is  present  as  free heavy 
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ity of class I molecules  in spleen and thymus from TAPl+[3B27 
and TAP1-[3B27  mice.  Splenocytes  (A) and  thymic  lobes  (B) 
were labeled biosynthetically for 20 min and 45 min, respectively, 
and chased for up to 4 h. Cell lysates were made and HLA-B27 
heavy chains  were  immunoprecipitated  with  mAbs  W6/32 or 
HC10. Immunoprecipitates were analyzed on 1D-1EF gels (cath- 
ode at top, anode at bottom).  Note the slight cross-reactivity  of 
W6/32 with  Db/h]32 m  complexes  in the  thymic  capsules.  Num- 
bered arrowheads indicate  the different  sialic acid modifications 
of the HLA-B27 heavy chains,  (C) Denatured and reduced ly- 
sates  from TAPl+I3B27,  TAPl-[3B27  and TAP1-  thymic  cap- 
sules were treated or mock treated with  endo H, separated by 
SDS-PAGE, immunoblotted,  and  probed with  mAb HC10  or 
anti-p8 serum to detect HLA-B27 and K  b, respectively. 
chains (Fig. 1 A, fourth panel). These heavy chains do not 
acquire sialic acid and are degraded during the chase (tl/2 
estimated to be 2-4 h).  Class I  complexes in TAPl-defi- 
cient cells may dissociate upon cell lysis (Townsend et al., 
1990);  the number of HLA-B27 complexes recovered by 
immunoprecipitation  in  the  TAPl-deficient  cells  and 
thymus therefore represents the lower limit of the amount 
of complexes present.  Some isoelectrically heterogenous 
polypeptides coimmunoprecipitating with the HC10 anti- 
body can be seen. They do not comigrate with the  sialy- 
lated forms of HLA-B27 (see first panel), and are insensi- 
tive to neuraminidase  treatment  (data  not  shown).  They 
could  represent  breakdown  products  of  the  HLA-B27 
heavy chains. This possibility has not been explored further. 
In the thymus of the TAPl+I3B27 mice, complex forma- 
tion of HLA-B27 heavy chains with h132m and their trans- 
port to the TGN, is observed (Fig. 1 B, first panel). Not all 
class  I  complexes are  modified by sialic acid  during  the 
chase. We attribute this to the less than optimal conditions 
under which the labeling of thymic tissue fragments is per- 
formed, as compared to labeling of activated splenic lym- 
phocytes in suspension. Free heavy chains are present at 
the onset of the chase (Fig. 1 B, third panel). These HLA- 
B27 free heavy chains remain unmodified. At least in Con 
A  blasts, such free heavy chains  are degraded  (Fig.  1 A, 
third and fourth panel),  and we suspect that degradation 
will also occur in the thymus, but difficulties of a technical 
nature  (cell death in culturing  thymic lobes) preclude us 
from  establishing  this  point  unambiguously  using  bio- 
chemical methods. 
Some HLA-B27 heavy chains  in  the  TAPl-I3B27 thy- 
mus form a  complex with h132m (Fig.  1 B, second panel), 
but remain unsialylated. This complex formation is more 
stable than in  activated spleen cells of these  mice. How- 
ever, the  majority of the  HLA-B27 heavy chains  is  still 
present as free heavy chains (Fig. 1 B, fourth panel). These 
data show that stable complex formation and transport of 
the HLA-B27 heavy chains in spleen and thymus is depen- 
dent on an intact TAP complex. 
We performed endo H digestions on class I molecules in 
the  thymus,  to  determine  more  accurately where  in  the 
secretory pathway the block in transport of HLA-B27 in 
TAPl-deficient cells manifests itself. Thymic capsules were 
directly lysed  under  denaturing  conditions,  treated  with 
endo H  and immunoblotted to determine the steady-state 
distribution  of the class I  molecules between the ER/cis- 
Golgi and more distal compartments. We determined the 
distribution of both the HLA-B27 molecules and the en- 
dogenous K b molecules by using the HC10 antibody and a 
serum specific for the cytoplasmic tail of K b (anti-p8), re- 
spectively.  The  HC10  antibody  does  not  react  with  the 
thymic extract  of TAP1-  mice, indicating  that  the  anti- 
body recognizes only the  HLA-B27 molecules (Fig.  1  C, 
HCIO panel).  Most HLA-B27 molecules detected  in  the 
TAPl+[3B27 thymic capsule are endo H  resistant, indicat- 
ing that at steady state most of these molecules are located 
beyond  the  ER/cis-Golgi  area.  This  observation  is  also 
consistent with the assertion that the occurrence of unsia- 
lylated HLA-B27 complexes observed in labeling experi- 
ments (Fig. 1 B) is due to suboptimal conditions of label- 
ing tissue fragments and does not correspond to a sizable 
pool of unsialylated HLA-B27 HCs at steady state. In con- 
trast, all HLA-B27 molecules detected in the TAP1-[3B27 
thymus remain endo H  sensitive, showing that the major- 
ity of molecules has failed to reach the medical Golgi. Un- 
like the HLA-B27 molecules, a  significant number of K b 
molecules in the TAPl-[3B27 thymus is resistant to endo 
H  treatment, in agreement with previous data (Alexander 
et al., 1989; Anderson et al., 1993; van Santen et al., 1995), 
which  have  shown  that  heterodimers  formed  between 
h[32m and murine class I heavy chains are transported to the 
cell surface in a  TAP-deficient background, owing to the 
greater stability of these heterodimers compared to their 
mouse-mouse counterparts. 
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a  functional TAP complex for proper assembly, folding, 
and  transport.  The  availability  of the  TAPl-13B27  and 
TAPl+[3B27 mice therefore allows us to compare the fate 
of assembled and unassembled MHC class I molecules in 
vivo by cytochemical methods. 
Distribution  of HLA-B27 in the Thymus 
To examine the pattern of expression of HLA-B27 in the 
thymus of the transgenic TAP1 +13B27 mice and compare it 
to that of endogenous class I molecules, we performed im- 
munofluorescence on cryosections from thymic tissue. 
To visualize the human class I HC we used the mono- 
clonal antibody HC10. The murine class I molecules were 
visualized with the rabbit polyclonal antibody anti-p8. Mu- 
rine class I  molecules in nontransgenic thymus are local- 
ized in a reticular staining in the cortical region (Fig. 2 A), 
characteristic of epithelial reticular cells. The intercellular 
spaces are filled by thymocytes which stain poorly if at all, 
because thymocytes, as a rule, are low in class I expression 
(Van  Ewijk,  1984).  The medullary area  displays a  more 
confluent staining of thymic stromal cells (Fig. 2 A). The 
labeling observed with the anti-p8  antibody is  similar to 
that described for class I  molecules in murine or human 
thymuses (Rouse et al., 1979; Van Ewijk et al., 1980; Janossy 
et al.,  1980).  Staining for HLA-B27 in the thymus of the 
TAPl+[3B27 mice is strong in cells of the cortex and me- 
dulla with a pattern of expression indistinguishable from 
that of the endogenous murine class I molecules (Fig. 2 B). 
Sections of thymus from a  nontransgenic animal did not 
stain with HC10, confirming that this antibody is specific 
for human class I HCs (Fig. 2 C). 
Immunofluorescence patterns  with  HC10  and  anti-p8 
antibodies in the thymus of TAPl-13B27 mice was similar 
to those observed in TAP1 ÷ animals, though the labeling 
intensity was lower (see below). 
Subcellular Localization  of HLA-B27 in Thymic 
Epithelial  Cells 
When comparing the steady-state levels of HLA-B27 by 
immunoblot,  we  observed  that  in  TAP1-  animals  the 
HLA-B27 HCs remain fully Endo H  sensitive (Fig. 1 C). 
This observation indicates that the intracellular transport 
of HLA-B27 synthesized in  the  absence of TAP-depen- 
dent peptides is blocked before medial-Golgi. To analyze 
the subcellular localization of HLA-B27 in the absence or 
in the presence of TAP1, we used immunogold cytochem- 
istry and electron microscopy. 
At the ultrastructural level thymic epithelial cells can be 
easily  distinguished  by  their  characteristic  nucleus  with 
dispersed chromatin, as well as by the presence of connect- 
ing desmosomes and bundles of cytokeratins, the so-called 
tonofilaments (Clark, 1963; Bearman et al.,  1978).  To im- 
munolocalize HLA-B27, we used a rabbit polyclonal anti- 
body recognizing class  1 heavy chains  (R  anti-hHC)  to 
avoid  having  to  use  a  bridging  antibody  (rabbit  anti- 
mouse IgG), necessary when using the HC10 antibody be- 
cause of its relatively poor direct reactivity with protein 
A-gold conjugates.  To establish  the specificity of the  R 
anti-hHC antibody, ultrathin cryosectiOns of thymus from 
Figure 2.  Immunofluorescence  localization  of endogenous  K  b 
(anti-p8  antibody)  and  transgenic  HLA-B27 molecules  (HC10 
antibody)  in thymic tissue from nontransgenic  (A  and  C) and 
TAPl÷I3B27 (B) mice. (A) K  b positive cells are detected in the 
thymic cortex (c) and in the thymic medulla (m). (B) HLA-B27 
shows a distribution similar to that of K  b positive cells in cortical 
and medullary cells. (C) No staining is detected in nontransgenic 
thymic tissue after immunolabeling with the monoclonal  HC10. 
Bars, 10 ~m. 
a  nontransgenic mouse were immunolabeled  (Fig.  3 A). 
No labeling above background was  detected, confirming 
the lack of cross-reaction with endogenous class  I  mole- 
cules. When using the R anti-hHC antibody, it is not possi- 
ble to attribute staining to free HC, or to HC that were 
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with  R  anti-hHC  antibody  upon  fixation of the  tissue. 
When reference is made to the distribution of HLA-B27 
HCs, this distribution therefore necessarily includes both 
free HCs and assembled complexes. In thymic tissue from 
a  TAP1+[3B27 mouse,  specific labeling is observed over 
the folded plasma membranes of epithelial cells (Fig. 3 B). 
When the thymus from a TAP1-13B27 animal was labeled 
with R  anti-hHC, a decrease in staining was observed on 
the plasma membrane of thymic epithelial cells (Fig. 3 C), 
indicating that in the absence of bound peptide, the major- 
ity of HLA-B27 HCs do not reach the plasma membrane. 
Quantitation of the labeling for HLA-B27 HCs over the 
plasma membrane of thymic epithelial cells from TAP1 ÷- 
13B27 and TAP1-[3B27 animals indicate that this reduction 
is at least 20-fold (Table I) (see also van Santen et al., 1995). 
HLA-B27 in thymic epithelial cells is also detected in- 
tracellularly. In  thymic epithelial cells of a  TAPl+I3B27 
mouse, HLA-B27 HCs are present in intracellular com- 
partments with a distinctive morphology, consisting of fen- 
estrated areas  and electron-dense, tubulated membranes 
(Fig. 4 B). In thymic epithelial cells from TAPl-deficient 
animals  these structures are more abundant  and appear 
expanded (Fig. 4 A). They, too, consist of electron-dense 
anastomosing tubular membranes and fenestrated regions 
enriched in class I HCs, and occupy a substantial area of 
the cytoplasm. Endoplasmic reticulum, labeled with an an- 
tibody directed against protein disulfide isomerase (PDI), 
is only poorly labeled for HLA-B27 HCs (Fig. 4 A). The 
HLA-B27 enriched compartments observed in thymic epi- 
thelial cells from TAP1 ÷ and TAP1- thymuses are very 
similar morphologically, yet the area of the cytoplasm that 
they  occupy  is  drastically  increased  in  TAPl-deficient 
cells. Morphometric analysis shows that in TAPl-deficient 
cells, the area of the network almost doubled (Table I), 
largely  the  consequence  of  expansion  of  the  electron- 
dense tubular membranes.  The density of gold particles 
specific for HLA-B27 HCs is also doubled. A  total three- 
fold increase in the labeling for HLA-B27 HCs per cell 
was  observed  (not shown).  Interestingly, in control ani- 
mals, compartments with similar morphology, though less 
expanded and in continuity with electron-dense tubules, 
contain endogenous class I  molecules visualized with an 
anti-murine HC  antibody raised  in  a  manner similar to 
that used for the R anti-hHC (Machold et al., 1995) (Fig. 4 
C). These observations, together with the finding that the 
majority  of  HLA-B27  in  TAPl-deficient  cells  remains 
Endo H  sensitive, lead us to conclude that improperly as- 
sembled class I molecules are massively retained in an ex- 
panded compartment. 
Morphological and Immunocytochemical 
Characterization of the Site of  Accumulation of 
HLA-B27 in TAPl-deficient Thymic 
Epithelial Cells 
In epon-embedded thymus sections of TAPl-I3B27  ani- 
mals, epithelial cells show a network of tubular and anas- 
tomosing electron-lucent areas of a morphology and intra- 
cellular position equivalent to that seen in cryosections. In 
the same region, ER cisternae displaying rough and smooth 
regions are present, suggesting that the network of smooth 
tubules is part of a post-ER/pre-Golgi region (Fig. 5). The 
morphology of the class I-enriched reticulum, as observed 
in plastic-embedded and positively contrasted material, is 
reminiscent of the site of assembly and accumulation of vi- 
rus  or  unassembled  viral  glycoproteins observed in  the 
CV1 and CHO cell lines (Kartenbeck et al., 1989; Hobman 
et al.,  1992).  An antibody that recognizes four ER mem- 
brane proteins and is known to label post-ER derivatives 
(Louvard et al., 1982; Noda and Farquar, 1992), stains the 
dense tubules and the vesiculated areas enriched in class I 
HCs (Fig. 6 A), confirming that the tubulo-vesicular pro- 
files are likely derived from, or are part of the ER. Double 
labeling  allowing  the  visualization  of human  HCs  and 
ERGIC-53, a known marker of the ER-Golgi intermedi- 
ate  compartment  (Schweizer et  al.,  1988,  1990), further 
confirms this interpretation.  Although this  antibody has 
been used to immunolocalize the human or primate mole- 
cule (Hobman et al., 1992), specific labeling is detected in 
the ER derived electron-dense tubules and fenestrated ar- 
eas in mouse tissue as well (Fig. 6 B). These results show 
that the extended network enriched for HLA-B27 mole- 
cules is indeed a post-ER/pre-Golgi network. 
Compartments Resembling Lysosomes Originate  from 
the Extended post-ER/pre-Golgi Network 
A  major question concerns the role of the extended net- 
work in which class I molecules accumulate: is it an inter- 
mediate station in the recycling of class I  molecules be- 
tween  the  Golgi  and  the  ER?  Is  it  implicated  in  the 
disposal of the accumulated class I molecules? Class I HCs 
are rarely observed in the Golgi stacks, whereas h132m is 
observed throughout the Golgi cisternae, even in TAP1- 
deficient cells (Fig. 7 A). The 132m subunit is normally syn- 
thesized in excess in relation to the HC, and is in fact a 
bona fida secretory protein. The observation that in TAP1- 
deficient cells 132m penetrates the secretory pathway into 
the Golgi complex, whereas the HC do not, illustrates the 
selective retention of improperly assembled (peptide-free) 
class I  molecules. In intact thymic lobes, biosynthetic la- 
beling reveals the presence of W6/32 reactive, assembled 
heterodimers, like  the  situation  encountered in T2 cells 
(Baas et al., 1992). Therefore, we may conclude that HLA- 
B27 class I heterodimers exist in TAP1- thymic epithelial 
cells, even though intracellular transport to the  Golgi is 
negligible  compared  to  their  TAP1 ÷  counterparts.  This 
fraction likely corresponds to the material detected in the 
post-ER/pre-Golgi compartment after double labeling for 
HLA-B27 HC and h132m. 
The HLA-B27 HC and h132m are also present in elec- 
tron-dense and smaller compartments consisting of con- 
densed tubular membranes and vesiculated regions (Fig. 7 
B). These compartments are observed in the same cells in 
which we observe the extended cis-Golgi reticulum. More 
electron-dense  compartments  showing  low  labeling  for 
HCs and 132m are also present (Fig. 7 B). These compart- 
ments also display proteins characteristic of intermediate 
compartments, illustrated by labeling performed with the 
antibody  directed  against  ERGIC-53  (not  shown).  The 
densest compartments observed are morphologically simi- 
lar to electron-dense lysosomes. 
The Journal of Cell Biology, Volume 131, 1995  1408 Figure 3.  Plasma membrane localization of HLA-B27 in thymic epi- 
thelial ceils from TAPl+I3B27 and TAP1-13B27  mice. Ultrathin cryo- 
sections from thymic tissue of a nontransgenic (A), TAP1 +13B27 (B) 
and TAPl-13B27 mice (C) were immunogold-labeled with the rabbit 
polyclonal serum raised against human HCs and protein A-10-nm 
gold (PAG 10). (A) No labeling is observed with this antibody on thy- 
mic epithelial cells of nontransgenic mice. (B) HLA-B27 HCs are de- 
tected on the plasma membrane (PM) of two adjacent cells. (C) Lit- 
tle labeling for HLA-B27 HCs is detected on the plasma membrane 
(PM) of TAPl-deficient thymic epithelial cells. (d, desmosomes; t, 
tonofilaments; PM, plasma membrane; N, nucleus.) Bars, 200 nm. 
Raposo  et al. ER-Golgi Intermediate Compartment  1409 Table L  tion.  In Fig.  10,  a  model is proposed for the disposal of 
HLA-B27 HCs.  TAP1  +13B27  TAP  13B27 
Plasma membrane  14  < 1 
(HLA-B27 HC) goldll~m 
Post-ER/pre-Golgi  network  63  110 
(HLA-B27 HC) gold/ixm  2 
Relative volume*  8%  15% 
Quantitation of HLA-B27  labeling  at the plasma  membrane  and in post-ER/pre-Golgi 
compartments in thymic epithelial cells from  TAPl+I3B27 and TAPl-13B27 mice. 
The number  of gold  particles  per txm plasma  membrane  and the number  of gold parti- 
cles per surface  area  were  determined  as described  in Materials  and Methods. 
*Relative  volume  occupied  by the HLA-B27  enriched  compartment. 
Ubiquitin and Ubiquitin-activating Enzymes Are 
Associated with the post-ER/pre-Golgi Network 
Studies  on the  disposal of intracisternal  granules  in thy- 
rotrophs previously showed a nonautophagic pathway for 
conversion of ER  cisternae  to  lysosomal like-organelles 
(Noda and Farquhar,  1992).  A  similar mechanism could 
operate in thymic epithelial cells for accumulated class I 
molecules. 
To investigate this possibility, we performed double la- 
beling,  allowing  the  visualization  of cathepsin  D  at  the 
sites  of accumulation  of HLA-B27  HCs.  The  extended 
compartment  with  tubulated/fenestrated  morphology  is 
not significantly labeled for cathepsin D  (Fig. 9 A), nor are 
the denser organelles (Fig. 8). In the same area of the cyto- 
plasm,  cathepsin  D-rich  lysosomes  are  clearly  present. 
Equivalent results were obtained with antibodies directed 
against LAMP1 or lgp120 (not shown). Nonlysosomal pro- 
teolysis may operate in parallel, and the ubiquitin-depen- 
dent pathway of protein degradation  is the major candi- 
date (Hershko and Ciechanover, 1992; Ciechanover, 1994). 
To test this hypothesis we explored whether ubiquitin and 
ubiquitin-activating enzyme E1  were associated with the 
post-ER/pre-Golgi network.  Clearly,  ubiquitin  is  associ- 
ated with the electron-dense tubules and fenestrated areas 
stained for the human HC (Fig. 9 A) and with the densest 
compartments (Fig. 9 B). The ubiquitin-activating enzyme 
E1 is also associated with electron-dense tubules (Fig. 9 C) 
and it is detected in association with organelles displaying 
condensed  class  I-positive tubulated  membranes (Fig.  9 
D). As compared with its presence in the cytosol, ubiquitin 
is  enriched  in  the  tubular  areas.  The  dimension  of the 
dense tubules and the size of the immunolabel preclude a 
determination of whether ubiquitin and E1 are inside the 
lumen of the tubules or at the cytosolic face of the tubule 
membranes  (Fig.  9,  A  and  C).  However these  proteins 
clearly reside  in the interior  of the  dense  compartments 
(Fig.  9,  B  and D). These  observations are in  agreement 
with the hypothesis that the pre-Golgi compartments can 
converge with the ubiquitin pathway of protein degrada- 
Discussion 
In the present study, we have used HLA-B27 transgenic 
mice and their TAP1 knockout counterparts (van Santen 
et al., 1995) to approach in an in vivo model and in situ the 
fate and subcellular localization of misfolded class I mole- 
cules. Using polyclonal and monoclonal antibodies recog- 
nizing  human  HC  and  human  [32  m,  the  localization  of 
HLA-B27 can be followed specifically without cross-reac- 
tion with endogenous murine class I molecules. 
The results show that in TAPl-deficient mice, (a) un- 
availability of peptide causes the vast majority of HLA- 
B27 HC and h[32m to remain unassembled. The HLA-B27 
HCs do not acquire sialic acids, are endo H  sensitive, and 
in Con A  blasts are degraded before arrival in the Golgi. 
In the thymus, we very much suspect a similar sequence of 
events,  but  cell death  in  the  course  of culturing  thymus 
fragments does not allow a  detailed biochemical analysis 
of such heavy chain breakdown in the thymus. (b) HLA- 
B27 HC and ~2  m accumulate in an expanded ER-Golgi in- 
termediate  compartment  displaying  anastomosing  tubu- 
lated and fenestrated membranes. (c) This compartment 
has its counterpart in nonmutant cells and (d) is associated 
with ubiquitin and the ubiquitin-activating enzyme El. 
In HLA-B27 transgenic mice, HLA-B27 is expressed at 
high  levels in the thymus and has a  cellular  distribution 
similar to that of the endogenous class I molecules in cells 
of both cortex and medulla, in  agreement with previous 
studies  on the  localization of MHC molecules in  thymic 
tissue (Rouse et al., 1979; Van Ewijk et al., 1980; Janossy 
et  al.,  1980;  Van Ewijk,  1984).  In thymic epithelial  cells 
from TAPl+[3B27 mice, at steady-state class I molecules 
are localized mainly at  the  plasma membrane, and  to  a 
lesser extent in intracellular compartments such as the ER 
and  Golgi  complex.  In  TAPl-deficient  cells,  HLA-B27 
HCs at the plasma membrane are reduced at least 20-fold, 
confirming that their stable expression at the cell surface is 
dependent on peptides translocated by TAP (Anderson et 
al., 1993; van Santen, 1995).  TAPl-deficient cells accumu- 
late HLA-B27 HCs and  [32m intracellularly in structures 
similar to those observed in the TAP1 + animals. However, 
in  TAPl-deficient  animals,  the  dense  tubulated  mem- 
branes and fenestrated regions are extended (almost dou- 
bled in volume), suggesting a direct link between the inhi- 
bition of intracellular  transport  of class I  molecules and 
the appearance and size of the compartment. In the T2 cell 
line, class I molecules are retained in the rough endoplas- 
mic reticulum (RER) and in the Golgi region (Baas et al., 
1992),  In another murine mutant cell line (CMT), class I 
molecules seem to be retained in smooth parts of the ER 
and  recycle through  the cis-Golgi reticulum  (Hsu et  al., 
Figure 4.  Intracellular localization of HLA-B27 and murine class I HCs in thymic epithelial  cells from TAPl-13B27  (A), TAPl+I3B27 
(B), and nontransgenic  (C) mice. Ultrathin cryosections from thymic tissue were immunogold-labeled  with the rabbit anti-serum raised 
against human HCs (PAG 10) (A and B) and with the rabbit anti-serum  raised against murine HCs (PAG 10) (C). In A, the ultrathin 
cryosection was also labeled with an antibody directed against protein disulfide isomerase (PDI) (PAG 15). (A) In TAPl-deficient cells 
the perinuclear region is filled with tubulated and fenestrated membranes heavily labeled for HLA-B27 HCs (PAG 10). Protein disul- 
The Journal of Cell Biology,  Volume 131, 1995  1410 fide isomerase (PDI) (PAG15) is detected in the RER (arrows). (B) In thymic epithelial cells from a TAPl+I3B27 mouse, HLA-B27 
HCs (PAG 10)  are detected in intracellular compartments  of similar morphology but smaller than in A. (C) In thymic epithelial cells 
from a nontransgenic mouse, murine HCs (PAG 10) can be detected in compartments with a fenestrated appearance continuous with 
electron dense tubules (arrows). N, nucleus; PM, plasma membrane. Bars, 200 nm. 
Raposo et al. ER-Golgi Intermediate Compartment  1411 Figure 5.  Morphology of the tubulo-vesicular  network in plastic-embedded thymic tissue of a TAP1-[3B27 mouse. Note the tubulated 
membranes close to the Golgi complex (G). In the same area rough ER cisternae show smooth surfaced subdomains (arrows). Bar, 200 nm. 
1990).  Morphologically the  smooth tubules with electron 
dense content are reminiscent of "smooth ER" close to, or 
in continuity with RER (Hobman et al., 1992).  The vesicu- 
lated areas that we observe in continuity with the tubules 
are similar to transitional elements described in pancreatic 
cells (Jamieson and Palade, 1967;  Oprins et al., 1993). To 
characterize the extended network enriched in class I mol- 
ecules, we used known markers allowing the identification 
of ER-Golgi intermediate compartments. Our results show 
that the dense tubulated areas are ER-derived, display ER 
membrane proteins, and are part of an extended interme- 
diate compartment identified by the presence of ERGIC- 
53 (Schweizer et al., 1990).  Tubulo-vesiculated areas local- 
ized between the Golgi and the ER have been identified as 
the site of assembly of vaccinia and hepatitis virus (Sodeik 
et al., 1992;  Krijnse-Locker et al., 1993), but they are not 
developed as extensively as is the site of accumulation of 
the E1 glycoprotein of the rubella virus in CHO cells (Hob- 
man et al., 1992).  A  post-ER, pre-Golgi compartment was 
identified as a differentiated proximal portion of the inter- 
mediate compartment (Hobman et al., 1992) and the com- 
plex tubular network accumulating class I HCs and 132m's 
described in the present study is morphologically similar. 
A  region of anastomosing tubular membranes in continu- 
ity with the RER, similar to the compartments referred to 
above, was also described as the site of accumulation of en- 
docytosed Simian virus 40 (Kartenbeck et al., 1989).  Our 
observations extend the  findings  on virus or viral glyco- 
proteins to other multimeric proteins such as class I mole- 
cules, and do so in primary cells in situ. A similar ER-derived 
structure, displaying dense-tubulated regions surrounding 
electron-lucent areas, was observed upon treatment of pan- 
creatic cells with Brefeldin A  (BFA) and was shown to ac- 
cumulate coatomers (Orci et al.,  1994).  Our results show 
that such subcompartmentalization of the ER can also be 
observed in cells not exposed to BFA. On the other hand, 
morphologically different ER-derived structures have been 
shown to accumulate high amounts of HMG-CoA reduc- 
tase in  CHO cells (Chin et al.,  1982)  and to concentrate 
chondroitin  sulfate  proteoglycan  precursors  in  chondro- 
cytes (Vertel et al., 1989). 
In th3;mic epithelial cells from TAPl+I3B27 mice, class I 
molecules are found in similar ER-Golgi intermediate com- 
partments  but  of  a  smaller  size.  Also,  in  nontransgenic 
normal animals class I molecules can be detected in similar 
structures. The ability of HLA-B27 to accumulate in smooth 
tubulated membranes is not a feature unique to thymic ep- 
ithelial  cells  because  in  L-fibroblasts  transfected  with 
HLA-B27 in the absence of human 132m, HCs are also lo- 
calized  in  electron-dense  tubules  in  the  cis-Golgi  region 
(Peters, P.  J., N. J.  Stam, and H. L. Ploegh, unpublished 
observations). The presence of class I molecules in the in- 
termediate  compartment  of thymic  epithelial  cells  from 
TAP1 ÷ animals may be due to high expression of HLA-B27, 
The Journal of Cell Biology, Volume 131,  1995  1412 Figure  6.  The  class  I-enriched tubulo-vesicular network  contains 
ER membrane proteins and the intermediate compartment marker 
protein (ERGIC-53). Ultrathin cryosections from thymic tissue of a 
TAP-[3B27 animal were double immunogold-labeled  with the rabbit 
anti-serum raised against human HCs and with a rabbit anti-serum 
directed against ER membrane proteins (A) or a  monoclonal di- 
rected  against ERGIC-53 (B).  (A) The  electron dense tubulated 
membranes intensely labeled with the anti-hHC antibody (PAG 10) 
are also reactive with the anti-ER antibody (PAG 15 nm). (B) HLA- 
B27 HCs (PAG 10) colocalize  with ERGIC-53 (PAG 15) in tubu- 
lated and fenestrated membranes. Bars, 200 nm. 
Raposo et al. ER-Golgi Intermediate Compartment  1413 Figure 7.  In thymic epithelial cells from TAP-[3B27 mice HLA-B27 HCs and h132m are localized in electron-dense compartments dis- 
playing tubulated membranes. (A) HLA-B27 hHCs (PAG I0) and h132m (PAG 15) colocalize in tubulated and fenestrated membranes 
close to the Golgi complex (G). Only the 132m subunit is detected in the Golgi complex. (B) HLA-B27 HCs (PAG 10) and h[32m (PAG 
15) are detected in compartments displaying tubulated and vesiculated regions reminiscent of the extended tubulo-vesiculated  network 
as well as in electron-dense organelles. Bars, 200 nm. 
The Journal  of Cell Biology, Volume 131, 1995  1414 Figure 8.  The HLA-B27--enriched  compartments are devoid of lysosomal  markers. Ultrathin cryosections  from thymic  tissue  of a 
TAP-13B27 mouse were double immunogold-labeled  with the rabbit anti-serum raised against human HCs and a rabbit anti-serum di- 
rected against cathepsin D. The labeling for HLA-B27 HC (PAG 10) and cathepsin D (PAG 15) is clearly segregated,  the lysosomal en- 
zyme being detected only in lysosomes (L). Bar, 200 nm. 
in addition to the endogenous murine class I molecules al- 
ready present in this region. For example, we do not know 
whether  the  amounts  of  class  I  molecules  present  in  a 
transgenic animal might saturate  a  component necessary 
for their ordered progression from the  ER to the  Golgi. 
The accumulation of HLA-B27 HCs could be compounded 
by the inability of HLA-B27 to bind murine self peptides 
with  affinities  comparable to  those  observed for human 
self peptides (Peters, P. J., N. J.  Stam, and H. L. Ploegh, 
unpublished observations). Consequently, "empty" mole- 
cules may accumulate in the course of biosynthesis in a sub- 
compartment of the ER. 
The  exact  role  of  the  intermediate  compartment  be- 
tween the Golgi and the ER remains to be unraveled. Stud- 
ies on virus assembly show the importance of the cis-Golgi 
region in the sorting of mature virions (Sodeik et al., 1993; 
Krijnse-Locker et  al.,  1994).  Intermediate compartments 
may also play an important role in fatty-acylation of pro- 
teins (palmitoylation), in the recycling of proteins from the 
Golgi to the ER, in the quality control of misfolded or un- 
assembled proteins, and may be directly implicated in ER- 
degradation mechanisms (Hammond and Helenius,  1994; 
Hauri and Schweizer, 1992). In TAPl-deficient cells a clear 
accumulation of class I HCs and [32m occurs in such a com- 
partment; they are predominantly present as free subunits, 
as analyzed biochemically in thymic cells and splenocytes. 
Our studies do not address the possible association of mis- 
folded HLA-B27 molecules with chaperones such as BIP 
or calnexin, as has been reported to occur for MHC class I, 
MHC class II or for viral glycoproteins (Degen and Wil- 
liams,  1991;  Bonnerot  et  al.,  1994;  Hammond and  Hele- 
nius,  1994).  As degradation  occurs at  a  pre-Golgi stage, 
the intermediate compartment itself likely plays a role in 
the disposal of class I molecules. 
In  agreement  with  the  assumption  that  the  extended 
post-ER/pre-Golgi network may be involved in diversion 
to or convergence with other intracellular routes, we have 
observed class I  HCs and h132m's in more electron-dense 
organelles.  These  lysosome-like structures  display inter- 
nal tubular membranes reminiscent of the electron-dense, 
smooth-ER  tubules,  suggesting  that  they  originate  from 
the condensation of the class I-enriched reticulum. A  non- 
autophagic pathway for diversion of ER proteins to lyso- 
somes  has  been  described  for  disposal  of  intracisternal 
granules in rat thyrotrophs (Noda and Farquhar, 1992).  In 
this ER-derived degradative pathway, RER elements lose 
their ribosomes and acquire a lysosome-like membrane as 
well as lysosomal enzymes. Even if the extended network 
we observe differs from the first steps of accumulation of 
intracisternal  granules  and  from  autophagy  (Noda  and 
Farquhar, 1992; Dunn, 1990; Rabouille et al., 1993), we won- 
der whether the more electron-dense compartments rep- 
Raposo et al. ER-Golgi Intermediate Compartment  1415 Figure 9.  The HLA-B27-enriched compartments contain ubiquitin and the ubiquitin-activating enzyme El. Ultrathin cryosections from 
thymic tissue of TAP-[3B27 mice were double- and triple-immunogold-labeled with the rabbit anti-serum raised against human HCs, 
with a monoclonal antibody directed against ubiquitin and with a rabbit anti-serum directed against cathepsin D  (A and B) or with a 
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Figure  10.  Diagram  depict- 
ing  the  proposed  ubiquitin- 
dependent  pre-Golgi  degra- 
dation  pathway  for  class  I 
molecules  in TAPl-deficient 
thymic epithelial  cells. In the 
absence  of  bound  peptides 
HC and  132m accumulate  in 
an  extended  network of tu- 
bulated membranes in conti- 
nuity  with the ER and close 
to the  Golgi complex.  Elec- 
tron-dense  compartments 
originate  from the compres- 
sion  of  the  extended  net- 
work.  Ubiquitin  and  ubiq- 
uiiin-activating  enzymes are 
progressively  enriched in the 
different  steps  of  compres- 
sion  of  the  post-ER-pre- 
Golgi network. 
resent a precursor stage in the diversion to lysosome-like 
organelles. The electron-dense compartments display pro- 
teins characteristic of intermediate compartments, such as 
ERGIC-53. This agrees with the suggestion that they are 
derived from the extended reticulum and with their local- 
ization in  the  pre-Golgi region.  Interestingly, these  lyso- 
some-like structures  are devoid of lysosomal enzymes or 
other  lysosomal proteins.  We  investigated  whether  such 
compartments could represent a diversion to a nonlysoso- 
mal pathway of degradation,  where  ubiquitin-dependent 
proteolysis would be a major candidate. There is at present 
no direct experimental evidence for involvement of ubiq- 
uitin in degradation of class I  molecules. Ubiquitin is co- 
valently ligated  to  protein  substrates  in  an  ATP-depen- 
dent  reaction  and  ubiquitin  ligation commits proteins  to 
degradation (Ciechanover, 1994; Hochstrasser, 1995).  Us- 
ing  antibodies  recognizing  ubiquitin  and  the  ubiquitin- 
activating enzyme (El), respectively, ubiquitin and E1 have 
been localized in the cell cytosol, in the nucleus, and in ly- 
sosomes and  autophagic vacuoles (Schwartz  et  al.,  1990, 
1992). These observations suggest that the ubiquitin path- 
way is operative at different intracellular locations. We ob- 
served ubiquitin and the ubiquitin-activating enzyme E1 in 
association  with  the  class  I-enriched  post-ER/pre-Golgi 
network and in electron dense organelles, suggesting the 
possibility of a link between this compartment and the ubiq- 
uitin  pathway  of degradation.  In  thymic epithelial  cells, 
ubiquitin is present in the nucleus and to a lesser extent in 
the cytoplasm, but appears to be concentrated in the class 
I-enriched profiles. In BHK cells overexpressing the cat- 
ion-independent mannose-6-phosphate receptor, electron- 
dense ER-derived tubules occur which accumulate MPR and 
are E1 positive (Klumperman, J., and H. J. Geuze, unpub- 
lished observations). As proposed by Schwartz (1990), our 
observations are in agreement with the notion of compart- 
mentalization of the ubiquitin pathway of degradation, as op- 
posed to being a homogeneously cytosolic phenomenon. 
ER-degradation has been the subject of numerous stud- 
ies. Several polypeptides including the asialoglycoprotein 
receptor, ribophorin, or T cell receptor subunits are known 
to be degraded by a  nonlysosomal endoproteolytic cleav- 
age that takes place in the ER itself or in ER-derived sub- 
compartments (Amara et al., 1989; Wikstrom and Lodish, 
1993;  Tsao et al.,  1992;  Klausner and  Sitia,  1990;  Bonifa- 
cino and Lippincott-Schwartz, 1991).  Our observations on 
thymic epithelial cells show that the ER-Golgi intermedi- 
ate station is complex and can be induced to expand, in re- 
sponse to the quantity and quality of passenger proteins. 
In the ER, misfolded and unassembled proteins are often 
relatively long-lived.  Frequently,  a  lag  period  with  little 
degradation is followed by rapid degradation, further sug- 
gesting that the proteins need to be transferred into spe- 
cific compartments or subregions of the ER (Hurtley and 
Helenius,  1989;  Klausner  and  Sitia,  1990).  In agreement 
with these  observations, our data reveal the  existence of 
ER-derived organelles most likely involved in the disposal 
of accumulated molecules (Fig.  10).  The unique  morpho- 
logical properties of this compartment suggest the  possi- 
bility  that  it  may be  purified  away from ER  and  Golgi 
membranes by subcellular fractionation. The ability to ex- 
ert  strict  control  over  the  folding  of  HLA-B27  in  the 
model described here should be a useful adjunct to such an 
endeavor and may assist in the further characterization of 
this compartment. 
monoclonal antibody directed  against the ubiquitin-activating  enzyme E1 (C and D). (A) Ubiquitin  (PAG 15) is detected in electron- 
dense tubules  and fenestrated membranes positive for HLA-B27 HC (PAG 10). No labeling is observed for cathepsin  D (PAG 5). (B) 
electron-dense compartment containing  ubiquitin  (PAG15) and some HLA-B27 HC (PAG 10). The ubiquitin-activating  enzyme E1 
(PAG 15) is detected in HLA-B27 HC (PAG 10) -positive tubules  (C) and in electron-dense  compartments displaying internal tubu- 
lated membranes (D). M, mitochondrion;  PM, plasma membrane. Bars, 200 nm. 
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